CN103183666A - Cyclopiazonic acid compound, and preparation and application thereof - Google Patents

Cyclopiazonic acid compound, and preparation and application thereof Download PDF

Info

Publication number
CN103183666A
CN103183666A CN2011104477016A CN201110447701A CN103183666A CN 103183666 A CN103183666 A CN 103183666A CN 2011104477016 A CN2011104477016 A CN 2011104477016A CN 201110447701 A CN201110447701 A CN 201110447701A CN 103183666 A CN103183666 A CN 103183666A
Authority
CN
China
Prior art keywords
cyclopiazonic acid
acid compounds
preparation
compound
cyclopiazonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011104477016A
Other languages
Chinese (zh)
Other versions
CN103183666B (en
Inventor
王楠
胡江春
刘祎
王书锦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Applied Ecology of CAS
Original Assignee
Institute of Applied Ecology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Applied Ecology of CAS filed Critical Institute of Applied Ecology of CAS
Priority to CN201110447701.6A priority Critical patent/CN103183666B/en
Publication of CN103183666A publication Critical patent/CN103183666A/en
Application granted granted Critical
Publication of CN103183666B publication Critical patent/CN103183666B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to the fields of medicines and novel pesticides, in particular to a cyclopiazonic acid compound and preparation and application thereof. The cyclopiazonic acid compound is 3-hydroxyl speradine A as described in formula (I) in the specification. The compound is used as a pesticide, a plant growth regulator or an antineoplastic drug. According to the invention, the novel cyclopiazonic acid compound with hydroxyl substitution at position 3 is obtained from marine sponge-associated fungi. The preparation of the compound provided by the invention is simple and efficient, and the prepared compound has high purity. A strain referred to in the invention has a reference value for further development and utilization of marine microbial resources.

Description

A kind of cyclopiazonic acid compounds and preparation and application
Technical field
The present invention relates to medicine and novel agrochemical field, be specially a kind of cyclopiazonic acid compounds and preparation and application.
Background technology
According to Food and Argriculture OrganizationFAO (FAO) report, can cause every year such as plant pest global grain drop in production to reach 31%-42%, directly threaten grain security.At present, the disease and pest problem of grain mainly relies on chemical synthetic pesticide and controls; But wherein there be low selectivity and the high toxicity of drug effect object in most of agricultural chemicals, also harmless or useful microorganism, insect and plant etc. is caused growth-inhibiting when killing target pest; Also can cause the problem of the aspects such as resistance, environmental pollution and food safety of insect.So searching low toxicity, environmentally friendly novel agrochemical are one and compel problem to be solved.
China is an ocean big country, has abundant Living marine resources; China also is a large agricultural country, has very strong dependency for the use of agricultural chemicals.The enforcement of this research will make the marine microorganism resource serve Agricultural Development better, and the novel low toxic and environment-friendly agricultural chemicals of development, reduce the toxicity agricultural chemicals usage quantity, ensure food safety and realize that the aspects such as sustainable development of agricultural have great importance.
The cyclopiazonic acid similar structures is very rare, has listed the natural product of all similar structures of present discovery in the accompanying drawing 1.Forefathers become to study to the intercrescence of α-cyclopiazonic acid, proved that it is to be developed by L-tryptophane, acetic acid, mevalonic acid, and its precursor compound are β-cyclopiazonic acid.It is to be derived by the D-tryptophane that the new compound iso-α that found in 2009-cyclopiazonic acid infers.Studies show that cyclopiazonic acid is by a part L-tryptophane, a part mevalonic acid, two molecule acetic acid synthesize, and β-cyclopiazonic acid is the precursor compound of cyclopiazonic acid.
Figure BDA0000126005520000011
Figure BDA0000126005520000021
Summary of the invention
The purpose of this invention is to provide a kind of cyclopiazonic acid compounds and preparation and application.
For achieving the above object, the present invention adopts technical scheme to be:
A kind of cyclopiazonic acid compounds, described cyclopiazonic acid compounds are 3-hydroxyl speradine A (3-hydroxyl speradine A), shown in (I):
Figure BDA0000126005520000022
There is the tautomer shown in figure (II) in E loop section shown in described (I) in the structural formula, and the E loop section can be expressed as following any structural unit;
Figure BDA0000126005520000031
Described E ring is (d) structure among the figure (II).
The preparation method of cyclopiazonic acid compounds:
1) aspergillus oryzae (Aspergillus oryzae) is inoculated in the liquid nutrient medium shake flask fermentation 6-10 days; Filter, filtrate is used absorption with macroporous adsorbent resin, and resin and filtrate mass volume ratio are for it than being 1: 10-30; After absorption is finished, use distilled water washing resin earlier, use the MeOH desorb again, get the cyclopiazonic acid crude extract behind the recovery methanol solvate;
2) the thick cyclopiazonic acid of gained separates with carrying out normal-phase chromatography in the step 1); At first removing non polar impurities with eluent ethyl acetate, is 90 with volume ratio: 10-80 again: ethyl acetate-methyl alcohol of 20 (v/v) wash-out, collect elution fraction, and namely get the chromatogram flow point that contains target compound;
3) above-mentioned gained chromatogram flow point adopts the anti-phase middle chromatogram of pressing to carry out purifying again, and adopting volume percent is the methanol aqueous solution wash-out of 50%-70%, collects elution fraction, namely gets the target compound of purity about 60%; Again the target compound of purity about 60% is carried out reversed-phase HPLC and carry out purifying, eluent is collected elution fraction for containing the methanol aqueous solution of trifluoroacetic acid (TFA), namely gets purity and is not less than 90% target compound.
Aspergillus oryzae (Aspergillus oryzae) was inoculated in the liquid nutrient medium shake flask fermentation 8 days; Fat is 20g/L with the ratio of filtrate.
The particle diameter of the silica filler that normal-phase chromatography separates described step 2) is 10-50 μ m.Described step 2) volume ratio of ethyl acetate-methyl alcohol is 85: 15 in.Pressing chromatograph packing material in anti-phase in the described step (3) is the ODS of particle diameter 40-60 μ m, and the ratio of ODS post wash-out methanol-water is 60%MeOH.Eluent is the methanol solution that contains the TFA of 0.03% concentration, wherein MeOH in the middle HPLC purifying of described step (3): the 0.03%TFA volume is=55-65: 45-35.Described MeOH: 0.03%TFA volume ratio=60: 40.
The application of cyclopiazonic acid compounds, described compound is as sterilant, plant-growth regulator or preparation anti-tumor drug.
Described compound is as the sterilant of control lepidoptera pest.The control lepidoptera pest is beet armyworm, Acariformes insect or carmine spider mite.
Described aspergillus oryzae is preserved in Chinese typical culture collection center (CCTCC) on December 26th, 2011, and preserving number is: CCTCC M 2011484, taxonomy called after: Aspergillus oryzae Hmp-F28.
Advantage of the present invention: the present invention obtains novel 3 cyclopiazonic acid compounds that exist hydroxyl to replace from coming from the ocean sponge fungi that grows nonparasitically upon another plant altogether.The effect that The compounds of this invention has excellent insecticidal activity, cytotoxic activity and promotes plant-growth.Preparation method provided by the present invention is simple, efficient simultaneously, products therefrom purity height.Bacterial strain involved in the present invention comes, and further development and use marine microorganism resource is had certain reference value.
Description of drawings
The compound that Fig. 1 provides for the embodiment of the invention 1H NMR (Bruker AV 600, CDCl 3) spectrogram.
The compound that Fig. 2 provides for the embodiment of the invention 13C NMR (Bruker AV 600, CDCl 3) spectrogram.
The compound that Fig. 3 provides for the embodiment of the invention 1H- 1H COSY (Bruker AV 600, Pyridine-d 5) spectrogram.
HSQC (Bruker AV 600, the CDCl of the compound that Fig. 4 provides for the embodiment of the invention 3) spectrogram.
HMBC (Bruker AV 600, the CDCl of the compound that Fig. 5 provides for the embodiment of the invention 3) spectrogram.
NOESY (Bruker AV 600, the Pyridine-d of the compound that Fig. 6 provides for the embodiment of the invention 5) spectrogram.
The ESI Q-TOF MS spectrogram of the compound that Fig. 7 provides for the embodiment of the invention
The plant growth regulation of the romaine lettuce seedling of compound 3-hydroxyl speradine A (Lactuca sativa) that Fig. 8 provides for the embodiment of the invention (wherein, figure A sample concentration: 100 μ g/ml, figure B sample concentration: 50 μ g/ml, figure C sample concentration: 10 μ g/ml.)。
Embodiment
The following examples will give further instruction to the present invention, but not thereby limiting the invention.
The present invention relates to new cyclopiazonic acid is 3-hydroxyl speradine A (3-hydroxyl speradine A).Its general structure is shown in structure (I):
Figure BDA0000126005520000051
There is the tautomer shown in figure (II) in E ring in this structural general formula, and the E ring can be expressed as any structural unit in (II).
Figure BDA0000126005520000052
The preparation method may further comprise the steps:
(1), the preparation of cyclopiazonic acid crude extract: after aspergillus oryzae liquid state fermentation, filter, filtrate is used absorption with macroporous adsorbent resin, namely gets thick cyclopiazonic acid with the methyl alcohol desorption again.
(2), the rough segmentation of target compound: the thick cyclopiazonic acid of gained carries out the normal-phase chromatography separation with flash chromatography (flash chromatography) in the step (1); Filler is silica gel, adopt ethyl acetate-methyl alcohol (EtOAc-MeOH) solvent systems to carry out gradient elution, at first remove non polar impurities with eluent ethyl acetate, be 90 with volume ratio again: 10-80: ethyl acetate-methyl alcohol of 20 (v/v) wash-out namely gets the chromatogram flow point of target compound.
(3), the purifying of target compound: the flow point that the middle gained of step (2) contains target compound adopts the anti-phase middle chromatogram of pressing to carry out purifying again; Filler is ODS, and the employing volume percent is the target compound that the methanol aqueous solution wash-out of 50%-70% namely gets purity about 60%.Further carrying out purifying with reversed-phase HPLC namely gets purity and is not less than 90% target compound.
In aforesaid method: the described fermentation time of step (1) is 6-10 days, is preferably 8 days.The described macroporous adsorbent resin of step (1) can be HP20 series, HPD series, and D101 series, any in the AB-8 series, and be not restricted to cited model.The usage ratio of the described macroporous adsorbent resin of step (1) and fermented liquid is 10g/L-30g/L, is preferably 20g/L.The easy volume ratio of ethyl acetate-methanol mixed that the described wash-out of step (2) obtains the target compound flow point is 90: 10-80: 20, be preferably 85: 15 (v/v).The solvent of the described wash-out ODS of step (3) reverse-phase chromatographic column is that volume percent is the methanol aqueous solution of 50%-70%, and preferred concentration is the methanol aqueous solution of 60% volume percent.The described eluent for the HPLC purifying of step (3) is the methanol aqueous solution (volume percent) that contains the 55-65% of 0.03% trifluoroacetic acid (TFA), is preferably 60% the methanol aqueous solution (volume percent) that contains 0.03% trifluoroacetic acid (TFA).
Embodiment 1:
Substratum: 1. YGP substratum: yeast extract paste 5g, glucose 10g, peptone 5g, sea salt water 1L (sea salt concentration: 2.5%).2. solid Martin substratum: glucose 10g, peptone 5g, K 2HPO 41g, MgSO 40.5g, agar 20g, sea salt water 1L (sea salt concentration: 2.5%).
The preparation of fermentation seed liquid: after streak inoculation on Martin's substratum, activation is 48 hours in 28 ℃ of incubators with aspergillus oryzae (Aspergillus oryzae Hmp-F28) bacterial strain.Spore inoculating after the picking activation is in the triangular flask of 3L in capacity, holds the YGP substratum of 1L in the triangular flask, places 28 ℃, cultivates in the 170rpm shaking table, waits to grow namely to can be used as fermentation seed liquid behind the bacterium ball and use about 48 hours.
The fermentation of bacterial strain Hmp-F28:
1. substratum: it is in the triangular flask of 3L that preparation YGP substratum 16L is sub-packed in 16 capacity, and every bottle of substratum is 1L, and 115 ℃ of autoclaving 30min cooling backs are standby.
2. inoculate and ferment: the seed liquor that makes previously with the pipette, extract after the sterilization is inoculated in the 16L fermented liquid, and inoculum size is 20ml/L.Then the 16L fermented liquid is placed 28 ℃, fermentation culture after 8 days in the 170rpm substratum, standby.
The preparation of target compound:
1. the preparation of cyclopiazonic acid crude extract: filtering fermentation liquor removed add HP20 type macroporous resin behind the thalline, resin demand is 20g/L, the fermented liquid that will add resin then jolt with 130rpm on the shaking table handle 1 hour after the elimination fermented liquid, then the gained resin is merged, and with after an amount of distilled water cleaning, add methyl alcohol and make methyl alcohol submergence resin, handle 20min at the 130rpm shaking table, meoh eluate is leached, use methanol-eluted fractions so repeatedly, and elutriant merged concentrating under reduced pressure, after the lyophilize meta-bolites crude extract 14.8g.
2. the rough segmentation of target compound: the particle diameter of silica filler is 10-50 μ m.The chromatographic column specification is: 70mm * 100mm.Adopt ethyl acetate-methyl alcohol (EtOAc-MeOH) solvent systems to carry out gradient elution, at first removing non polar impurities with eluent ethyl acetate, is 364.8 milligrams of the chromatogram flow points that ethyl acetate-methyl alcohol (v/v) wash-out of 85: 15 must contain target compound with volume ratio again.
3. the purifying of target compound: above-mentioned flow point adopted again press chromatogram to carry out purifying in anti-phase; Filler is ODS; The chromatographic column specification is 15mm * 70mm; ODS loading amount 4.0g.Adopting volume percent is that namely to get purity be 61.3% target compound for 60% methanol aqueous solution wash-out.Further carry out purifying with reversed-phase HPLC.The HPLC condition is: the chromatographic column specification is 10mm * 250mm; Flow velocity 2.5ml/min; Detect wavelength 220nm; Moving phase is the methanol aqueous solution that contains the volume percent 60% of 0.03%TFA; Type of elution: isocratic elution; Flow velocity is 2.5ml/min; The collection retention time is that the chromatographic peak of 13.7min namely gets target compound 3-hydroxyl speradine A.Its purity is 94%.
Structure with the greening compound is identified
The comprehensive 1D that adopts, 2D NMR, MS, spectrum means such as CD have been identified the chemical structure of this compound, and nuclear magnetic data has been given ownership.
ESI-Q-TOF MS m/z 405.1425[M+Na] +(calcd.for C 21H 22N 2O 5Na, 405.1421), so the deduction molecular formula is C 21H 22N 2O 5
[ α ] D 20 = - 233.5 ( c = 0.5 , CHCl 3 )
Present negative cotton effect at the 220nm place on the CD spectrogram, the cotton effect appears in 290nm.Determine that 5 of compounds are the S configuration; Determine that in conjunction with NOESY spectrum this compound steric configuration is: 4S, 5S, 11R.
1H-NMR(600MHz,CDCl 3)δ2.60(1H,brd,J=11.1Hz,H-5),2.74(1H,d,J=14.3Hz,H-12a),6.91(1H,d,J=7.4Hz,H-14),7.30(1H,t,J=7.4Hz,H-15),6.71(1H,d,J=7.4Hz,H-16),2.31(3H,s,H-20),1.11(3H,s,H-21),1.70(3H,s,H-22),3.25(3H,s,H-23)。
1H-NMR(600MHz,pyridine-d 5)δ3.54(1H,t,J=8.16Hz,H-4),3.30(1H,m,H-11),3.36(1H,dd,J=9.72,15.1Hz,H-12b)。
13C-NMR(150MHz,CDCl 3)δ179.1(C-2),73.3(C-3),46.3(C-4),68.3(C-5),192.1(C-6),104.7(C-7),171.6(C-8),62.5(C-10),51.3(C-11),25.8(C-12),136.2(C-13),121.9(C-14),131.3(C-15),106.4(C-16),142.9(C-17),124.8(C-18),184.7(C-19),19.5(C-20),24.9(C-21),27.6(C-22),26.8(C-23)。
1H NMR (Bruker AV 600, CDCl 3) spectrogram is referring to Fig. 1.
13(Bruker AV 600, CDClx) spectrogram is referring to Fig. 2 for C NMR.
1H- 1H COSY (Bruker AV 600, Pyridine-d 5) spectrogram is referring to Fig. 3.
HSQC (Bruker AV 600, CDCl 3) spectrogram sees attached referring to Fig. 4
HMBC (Bruker AV 600, CDCl 3) spectrogram sees attached referring to Fig. 5.
NOESY (Bruker AV 600, Pyridine-d 5) spectrogram is referring to Fig. 6.
ESI Q-TOF MS spectrogram is referring to Fig. 7.
Embodiment 2:
Experimental technique:
1. the processing of sample: after the 3-hydroxyl speradine A taking-up that is chilled in before above-described embodiment gained compound in subzero 20 ℃ of refrigerators, be mixed with 1mg/mL, 0.5mg/mL, 0.25mg/mL, 0.125mg/mL, six kinds of concentration of 0.0625mg/mL by doubling dilution, sample number amounts to 36, and is standby.2. the hatching of halogen worm: halogen worm artemia hatching solution: see (Solis P N, Wright C W, Anderson M M et al. (1993) .A microwell cytotoxicity assay using Artemia salina (brine shrimp) .Planta Medica, 59 (3), 250-252. 3. halogen worm bioassay method: get the front with liquid-transfering gun and dilute good sample 100 μ L in the hole of 96 orifice plates, add 100 μ L halogen worm larva suspension (Halogen worm 15-20 only) again, sample concentration just has been diluted into 0.5mg/mL like this, 0.25mg/mL, 0.125mg/mL, 0.0625mg/mL, 0.03125mg/mL, each concentration repeats 3, do blank with halogen worm larva suspension, in 28 ℃ of illumination boxs, placed 24 hours, observe with the binocular anatomical lens, record halogen worm death toll, HCl with 4mol/L puts to death all halogen worms then, record halogen worm sum.And (1) calculation correction mortality ratio by formula.
Figure BDA0000126005520000081
Experimental result:
The deadly activity of the table 1. compound 3-hydroxyl halogen worm of speradine A (brine shrimp)
Figure BDA0000126005520000082
Calculate its LD 50Be 39.7 μ g/mL.By this embodiment as can be seen the halogen worm of 3-hydroxyl speradine A have very strong deadly activity.Therefore has the good prospect that can be developed as sterilant.
Embodiment 3:
Employing is tested based on romaine lettuce (Lactuca sativa) growth of seedling of 24 orifice plates:
Romaine lettuce (Lactuca sativa) seed is that the big speed of the U.S. is given birth to.The seed of choosing full grains is put into the micropore of 24 orifice plates that are covered with filter paper, 10 seeds in every hole.Above-mentioned gained 3-hydroxyl speradine A is mixed with 10,50, the aqueous solution of 100 μ g/ml.Every hole adds the sample solution of 200 μ L.4 repetitions of each sample.Control group adopts the distilled water that adds 200 μ L.Cultivate in illumination box the sealing back.Culture condition is temperature: 19C, light application time 16 hours.Have growth of seedling and carefully take out the long and cauline leaf length of seedling measurement seedling root after 5 days.
Experimental result: as shown in Figure 8,3-hydroxyl speradine A just can show the growth-promoting effect to root and stem under the lower concentration of 10 μ g/ml.Growth table to root when concentration is 50 μ g/ml reveals the strongest promoter action.Yet along with the rising of concentration, when 100 μ g/ml, though the growth of stem is had certain promoter action, the growth table of root is revealed very obvious suppression effect.Experiment shows that 3-hydroxyl speradine A (<50 μ g/ml) under lower concentration shows the promoter action to growth of seedling, and shows the restraining effect to growth of seedling when high density (0.1-2mg/ml).When 100 μ g/ml, show the obvious restraining effect to root, and not remarkable to the influence of stem.Along with the reduction of concentration, root and stem are all shown significant growth promoting function.This shows that above-described embodiment gained compound shows the growth regulating effect of the plant hormone sample that lower concentration promotes, high density suppresses.This may structurally show with indolylacetic acid (IAA) with above-described embodiment gained compound has the approximate hydrophilic segment of similar hydrophobic part and space length, thereby presents the similar hormone-like effect with IAA.
Embodiment 4:
The experiment of cell in vitro cytotoxic activity:
Cell cultures: the human body tumour cell in the vegetative period of taking the logarithm is 5 * 10 with the RPMI-1640 nutrient solution dilution that includes 10% (v/v) foetal calf serum (fetal bovine serum) 4The cell suspending liquid of/L is inoculated in 96 orifice plates, 100 μ L/ holes.Place 37 ℃, saturated humidity, 5%CO 2Cultivate 24h in the incubator.
Add specimen: behind the compound sample with DMSO dissolving above-described embodiment institute, diluting with the RPMI-1640 nutrient solution that contains 10% (v/v) foetal calf serum is 7.6,38,76,152,380 μ mol/L.Above-mentioned pastille nutrient solution is added in 96 orifice plates, be positioned in the incubator with cell cultures the same terms and cultivate 48h.
The mtt assay result measures: add 20 μ L MTT solution (5mg/mL in RPMI-1640 nutrient solution) after adding specimen processing 48h.The centrifugal supernatant liquor of removing behind the dyeing 4h.Add DMSO, measure OD value under the 570nm with microplate reader.
Data analysis is calculated in accordance with the following methods:
(1). inhibitory rate of cell growth=[1-administration group OD value/control group OD value] * 100%.
(2). adopt the LOGIT method to calculate medicine half-inhibition concentration (IC 50).
Test-results: the human melanoma cell of 3-hydroxyl speradine A (A375-S2) and human cervical carcinoma cell (HeLa) all show tangible cytotoxic activity, two kinds of cell strain inhibiting rates and IC 50Value is respectively 43.3 μ mol/L and 29.6 μ mol/L.
This shows that 3-hydroxyl speradine A has potential anti-tumor activity, further is developed as the possibility of cancer therapy drug again.

Claims (12)

1. cyclopiazonic acid compounds, it is characterized in that: described cyclopiazonic acid compounds is 3-hydroxyl speradine A (3-hydroxyl speradine A), shown in (I):
Figure FDA0000126005510000011
2. by the described cyclopiazonic acid compounds of claim 1, it is characterized in that: there is the tautomer shown in figure (II) in the E loop section shown in described (I) in the structural formula, and the E loop section can be expressed as following any structural unit;
Figure FDA0000126005510000012
3. by the described cyclopiazonic acid compounds of claim 2, it is characterized in that: described E ring is (d) structure among the figure (II).
4. the preparation method of the described cyclopiazonic acid compounds of claim 1 is characterized in that:
1) aspergillus oryzae (Aspergillus oryzae) is inoculated in the liquid nutrient medium shake flask fermentation 6-10 days; Filter, filtrate is used absorption with macroporous adsorbent resin, and resin and filtrate mass volume ratio are for it than being 1: 10-30; After absorption is finished, use distilled water washing resin earlier, use the MeOH desorb again, get the cyclopiazonic acid crude extract behind the recovery methanol solvate; Described aspergillus oryzae is preserved in Chinese typical culture collection center (CCTCC) on December 27th, 2011, and preserving number is: CCTCC M 2011484, taxonomy called after: Aspergillus oryzae Hmp-F28;
2) the thick cyclopiazonic acid of gained separates with carrying out normal-phase chromatography in the step 1); At first removing non polar impurities with eluent ethyl acetate, is 90 with volume ratio: 10-80 again: ethyl acetate-methyl alcohol of 20 (v/v) wash-out, collect elution fraction, and namely get the chromatogram flow point that contains target compound;
3) above-mentioned gained chromatogram flow point adopts the anti-phase middle chromatogram of pressing to carry out purifying again, and adopting volume percent is the methanol aqueous solution wash-out of 50%-70%, collects elution fraction, namely gets the target compound of purity about 60%; Again the target compound of purity about 60% is carried out reversed-phase HPLC and carry out purifying, eluent is collected elution fraction for containing the methanol aqueous solution of trifluoroacetic acid (TFA), namely gets purity and is not less than 90% target compound.
5. the preparation method of the described cyclopiazonic acid compounds of claim 4 is characterized in that: aspergillus oryzae (Aspergillus oryzae) was inoculated in the liquid nutrient medium shake flask fermentation 8 days; Fat is 20g/L with the ratio of filtrate.
6. the preparation method of the described cyclopiazonic acid compounds of claim 4 is characterized in that: the particle diameter of the silica filler that normal-phase chromatography separates described step 2) is 10-50 μ m.
7. the preparation method of the described cyclopiazonic acid compounds of claim 4 is characterized in that: the volume ratio of ethyl acetate-methyl alcohol is 85: 15 described step 2).
8. the preparation method of the described cyclopiazonic acid compounds of claim 4 is characterized in that: pressing chromatograph packing material in anti-phase in the described step (3) is the ODS of particle diameter 40-60 μ m, and the ratio of ODS post wash-out methanol-water is 60%MeOH.
9. the preparation method of the described cyclopiazonic acid compounds of claim 4 is characterized in that: in the described step (3) in the HPLC purifying eluent be the methanol solution that contains the TFA of 0.03% concentration, wherein MeOH: the 0.03%TFA volume is=55-65: 45-35.
10. the preparation method of the described cyclopiazonic acid compounds of claim 9 is characterized in that: MeOH: 0.03%TFA volume ratio=60: 40.
11. the application of the described cyclopiazonic acid compounds of claim 1 is characterized in that: described compound is as sterilant, plant-growth regulator or preparation anti-tumor drug.
12. the application by the described cyclopiazonic acid compounds of claim 11 is characterized in that: described compound is as the sterilant of control lepidoptera pest.
CN201110447701.6A 2011-12-28 2011-12-28 Cyclopiazonic acid compound, and preparation and application thereof Expired - Fee Related CN103183666B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110447701.6A CN103183666B (en) 2011-12-28 2011-12-28 Cyclopiazonic acid compound, and preparation and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110447701.6A CN103183666B (en) 2011-12-28 2011-12-28 Cyclopiazonic acid compound, and preparation and application thereof

Publications (2)

Publication Number Publication Date
CN103183666A true CN103183666A (en) 2013-07-03
CN103183666B CN103183666B (en) 2014-09-17

Family

ID=48675143

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110447701.6A Expired - Fee Related CN103183666B (en) 2011-12-28 2011-12-28 Cyclopiazonic acid compound, and preparation and application thereof

Country Status (1)

Country Link
CN (1) CN103183666B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104370917A (en) * 2014-05-14 2015-02-25 福州大学 Indole terpene speradine H derived from aspergillus oryzae and application
CN104370916A (en) * 2014-05-14 2015-02-25 福州大学 Indole terpene speradine B derived from aspergillus oryzae and application
CN104370928A (en) * 2014-05-14 2015-02-25 福州大学 Indole terpene speradine F derived from aspergillus oryzae and application
CN104387396A (en) * 2014-05-14 2015-03-04 福州大学 Indole terpene speradine E derived from aspergillus oryzae and application
CN110527636A (en) * 2018-05-25 2019-12-03 中国科学院沈阳应用生态研究所 A kind of mutant strain synthesizing cyclopiazonic acid derivative and its construction method and application
CN111139189A (en) * 2020-01-14 2020-05-12 浙江工业大学 Aspergillus WBX-38 and application thereof in production of cyclopiazonic acid

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MASASHI TSUDA,ET AL.,: "Speradine A, a new pentacyclic oxindole alkaloid from a marine-derived fungus Aspergillus tamarii", 《TETRAHEDRON》 *
SONIA MIRANDA,ET AL.: "Convenient Synthesis of Highly Functionalized, 3,4-Disubstituted Indole Building Blocks", 《THE OPEN ORGANIC CHEMISTRY JOURNAL》 *
W.R.CHRISTIAN BEYER, ET AL,: "Asymmetric total synthesis of the indole alkaloid cyclopiazonic acid and first structureeactivity data", 《TETRAHEDRON》 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104370917A (en) * 2014-05-14 2015-02-25 福州大学 Indole terpene speradine H derived from aspergillus oryzae and application
CN104370916A (en) * 2014-05-14 2015-02-25 福州大学 Indole terpene speradine B derived from aspergillus oryzae and application
CN104370928A (en) * 2014-05-14 2015-02-25 福州大学 Indole terpene speradine F derived from aspergillus oryzae and application
CN104387396A (en) * 2014-05-14 2015-03-04 福州大学 Indole terpene speradine E derived from aspergillus oryzae and application
CN104387396B (en) * 2014-05-14 2016-08-24 福州大学 Come from indole terpene speradine E and the application of aspergillus oryzae
CN104370916B (en) * 2014-05-14 2016-08-24 福州大学 Come from indoles terpene speradine B and the application of aspergillus oryzae
CN104370917B (en) * 2014-05-14 2016-08-24 福州大学 Come from indole terpene speradine H and the application of aspergillus oryzae
CN110527636A (en) * 2018-05-25 2019-12-03 中国科学院沈阳应用生态研究所 A kind of mutant strain synthesizing cyclopiazonic acid derivative and its construction method and application
CN111139189A (en) * 2020-01-14 2020-05-12 浙江工业大学 Aspergillus WBX-38 and application thereof in production of cyclopiazonic acid
CN111139189B (en) * 2020-01-14 2022-04-19 浙江工业大学 Aspergillus WBX-38 and application thereof in production of cyclopiazonic acid

Also Published As

Publication number Publication date
CN103183666B (en) 2014-09-17

Similar Documents

Publication Publication Date Title
CN103183666B (en) Cyclopiazonic acid compound, and preparation and application thereof
CN110527629B (en) Marine fungus-derived brefeldin A, preparation method and application thereof in resisting agricultural pathogenic bacteria
CN103740606A (en) Streptomyces phytohabitans, method for producing new antibiotics Novonestmycin from Streptomyces phytohabitans, and application of Novonestmycin
CN102994418B (en) Methylotrophic bacillus for producing surfactins and iturin A compounds and application of methylotrophic bacillus
CN106432168B (en) The anti-vibrios reactive compound and preparation method thereof in mangrove cusp sea lotus endogenetic fungus source
CN103724190B (en) Compound EngyodontiuminA in the secondary fungus metabolite of a kind of deep-sea, preparation method and its usage
CN100494189C (en) Benzofurantone compound, its production and use
CN110863021A (en) Preparation method and application of cytochalasin compound
CN104098585B (en) Mibemycin analogue, its preparation method and application
CN109295122A (en) A kind of Preparation method and use of E. exserta endogenetic fungus Chaetomium sp secondary metabolite
CN112795617B (en) Marine fungus secondary metabolite and preparation and application thereof
CN106432169B (en) A kind of active isocoumarin class compound of anti-vibrios and its crystal
CN106831696B (en) Macrolide derivative and preparation method and application thereof
CN116515637A (en) Aspergillus strain, application thereof and method for producing aspergillone
CN109400444A (en) Inhibit the sesquiterpenoids and preparation method thereof of plant pathogenic fungi
CN103361276B (en) Saccharopolyspora spinosa HBERC-25376, culturing method thereof as well as separation method and application of active substances thereof
CN107226800A (en) A kind of xanthone classes compound and its preparation method of monocrystalline and the application as anti-Mycobacterium marinum medicine
CN102168119B (en) Method for preparing diaporthein B and application of diaporthein B to preparation of antitumor medicaments
CN107226801A (en) A kind of xanthone classes compound and its preparation method of monocrystalline and the application as alpha-glucosidase restrainer
CN104988193A (en) Production method for 10, 11-dehydrogenated curvularin and application thereof
CN100430361C (en) Quinone compounds and its preparation method and antineoplastic use
CN1243100C (en) Method for production of cytosporasp B and the use in preparation of anti-tumor and antifungal medicine
CN115894180B (en) Method for separating mycotoxin from metabolite of black spot bacteria of ginseng
CN104370928B (en) Come from indole terpene speradine F and the application of aspergillus oryzae
CN109503623B (en) Guanactastane compound, preparation method thereof and application thereof in preparation of antibacterial drugs

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140917

Termination date: 20211228